{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T21:13:37Z","timestamp":1726002817581},"publisher-location":"Vienna","reference-count":74,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783211831144"},{"type":"electronic","value":"9783709164679"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998]]},"DOI":"10.1007\/978-3-7091-6467-9_17","type":"book-chapter","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T01:23:41Z","timestamp":1349486621000},"page":"185-197","source":"Crossref","is-referenced-by-count":6,"title":["Biological markers for the diagnosis of Alzheimer\u2019s disease"],"prefix":"10.1007","author":[{"given":"C.","family":"Bancher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Jellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Wichart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ana.410380414","volume":"38","author":"H Arai","year":"1995","unstructured":"Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Machida N, Seiki H, Takase S, Clark CM, Lee VM-Y, Trojanowski JQ, Sasaki A (1995) Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer\u2019s disease. Ann Neurol 38: 649\u2013652","journal-title":"Ann Neurol"},{"issue":"1","key":"17_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000213879","volume":"43","author":"H Arai","year":"1997","unstructured":"Arai H, Higuchi S, Sasaki H (1997) Apolipoprotein E genotyping and cerebrospinal fluid tau protein \u2014 implications for the clinical diagnosis of Alzheimer\u2019s disease. Gerontology 43 [Suppl 1]: 2\u201311","journal-title":"Gerontology"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0006-8993(89)91396-6","volume":"477","author":"C Bancher","year":"1989","unstructured":"Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer\u2019s disease. Brain Res 477: 90\u201399","journal-title":"Brain Res"},{"key":"17_CR4","first-page":"195","volume-title":"Current research in Alzheimer therapy II. Early diagnosis","author":"C Bancher","year":"1991","unstructured":"Bancher C, Wisniewski HM, Mehta PD, Kim KS, Grundke-Iqbal I, Iqbal K (1991) Biochemical markers for Alzheimer\u2019s disease as reflection of the neuropathology in cerebrospinal fluid. In: Becker RE, Giacobini E (eds) Current research in Alzheimer therapy II. Early diagnosis. Taylor and Francis, New York, pp 195\u2013216"},{"key":"17_CR5","first-page":"2534","volume":"5","author":"K Blennow","year":"1994","unstructured":"Blennow K, Hesse C, Fredman P (1994a) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer\u2019s disease. Neuro Report 5: 2534\u20132536","journal-title":"Neuro Report"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S1041610294001584","volume":"6","author":"K Blennow","year":"1994","unstructured":"Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L (1994b) First place. 1993 IPA research awards in psychogeriatrics: ubiquitin in cerebrospinal fluid in Alzheimer\u2019s disease and vascular dementia. Int Psychogeriatr 6: 13\u201322","journal-title":"Int Psychogeriatr"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF02260939","volume":"8","author":"K Blennow","year":"1994","unstructured":"Blennow K, Wallin A, Ekman R (1994c) Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neurronal degeneration in dementia disorders? J Neural Transm [P-D Sect] 8: 183\u2013191","journal-title":"J Neural Transm [P-D Sect]"},{"key":"17_CR8","first-page":"231","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E (1995a) Tau protein in cerebrospinal fluid. A biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26: 231\u2013245","journal-title":"A biochemical marker for axonal degeneration in Alzheimer disease"},{"key":"17_CR9","first-page":"306","volume":"6","author":"K Blennow","year":"1995","unstructured":"Blennow K, Davidsson P, Wallin A, Ekman R (1995b) Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer\u2019s disease. Dementia 6: 306\u2013311","journal-title":"Dementia"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/neur.1995.0023","volume":"4","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Chong JK (1995c) Cerebrospinal fluid \u201cneuronal thread protein\u201d comes from serum by passage over the blood-brain barrier. Neurodegeneration 4: 187\u2013193","journal-title":"Neurodegeneration"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0304-3940(96)12905-0","volume":"214","author":"M Blomberg","year":"1996","unstructured":"Blomberg M, Jensen M, Basun H, Lannfelt L, Wahlund LO (1996) Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up. Neurosci Lett 214: 163\u2013166","journal-title":"Neurosci Lett"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-lbeta and interleukin 6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci Lett 202: 17\u201320","journal-title":"Neurosci Lett"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1212\/WNL.46.6.1715","volume":"46","author":"JG Csernansky","year":"1996","unstructured":"Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW (1996) CSF excitatory amino acids and severity of illness in Alzheimer\u2019s disease. Neurology 46: 1715\u20131720","journal-title":"Neurology"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF02815094","volume":"27","author":"P Davidsson","year":"1996","unstructured":"Davidsson P, Jahn R, Bergquist J, Ekman R, Blennow K (1996) Synaptotagmin, a synaptiv vesicle protein, is present in human ceerebrospinal fluid: a new biochemichal marker for synaptic pathology in Alzheimer disease? Mol Chem Neuropathol 27: 195\u2013210","journal-title":"Mol Chem Neuropathol"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ana.410320606","volume":"32","author":"SM Monte De la","year":"1992","unstructured":"De la Monte SM, Volicer L, Hauser SR, Wands JR (1992) Incresed levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 32: 733\u2013742","journal-title":"Ann Neurol"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1001\/archneur.1987.00520160041012","volume":"44","author":"R Elble","year":"1987","unstructured":"Elble R, Giacobini E, Scarsella GF (1987) Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease. Arch Neurol 44: 403\u2013407","journal-title":"Arch Neurol"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1212\/WNL.48.3.632","volume":"48","author":"D Galasko","year":"1997","unstructured":"Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P (1997) Assessmant of cerebrospinal fluid levels of tau in mildly demented patients with Alzheimer\u2019s disease. Neurology 48: 632\u2013635","journal-title":"Neurology"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913\u20134917","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"11949","DOI":"10.1073\/pnas.89.24.11949","volume":"89","author":"D Gunnersen","year":"1992","unstructured":"Gunnersen D, Haley B (1992) Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker. Proc Natl Acad Sci USA 89: 11949\u201311953","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-3940(97)13477-2","volume":"224","author":"S Hahne","year":"1997","unstructured":"Hahne S, Nordsted C, Ahlin A, Nyback H (1997) Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer\u2019s disease and healthy controls. Neurosci Lett 224: 99\u2013102","journal-title":"Neurosci Lett"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0304-3940(97)00379-0","volume":"228","author":"H Hampel","year":"1997","unstructured":"Hampel H, Schoen D, Schwarz MJ, Kotter HU, Schneider C, Sunderland T, Dukoff R, Levy J, Padberg F, Stubner S, Buch K, Muller N, Moller HJ (1997) Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer\u2019s disease. Neurosci Lett 228: 143\u2013146","journal-title":"Neurosci Lett"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1006\/bbrc.1994.1760","volume":"201","author":"PN Hawkins","year":"1994","unstructured":"Hawkins PN, Rossor MN, Gallimore JR, Miller B, Moore EG, Pepys MB (1994) Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer\u2019s disease. Biochem Biophys Res Commun 201: 722\u2013726","journal-title":"Biochem Biophys Res Commun"},{"key":"17_CR23","first-page":"175","volume":"7","author":"K Isoe","year":"1996","unstructured":"Isoe K, Urakami K, Shimomura T, Wakutani Y, Ji Y, Adachi Y, Takahashi K (1996) Tau proteins in cerebrospinal fluid from patients with Alzheimer\u2019s disease: a longitudinal study. Dementia 7: 175\u2013176","journal-title":"Dementia"},{"key":"17_CR24","first-page":"239","volume":"95","author":"M Jensen","year":"1995","unstructured":"Jensen M, Basun H, Lannfelt L (1995) Increased cerebrospinal fluid tau in patients with Alzheimer\u2019s disease. J Neurol Sci 95: 239\u2013258","journal-title":"J Neurol Sci"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/BF01291887","volume":"104","author":"FJ Jimenez-Jimenez","year":"1997","unstructured":"Jimenez-Jimenez FJ, Debustos F, Molina JA, Benitoleon J, Tallonbaranco A, Gasalla T, Ortipareja M, Guillamon F, Rubio JC, Arenas J, Enriquezdesalamanca R (1997) Cerebrospinal fluid levels of alpha-tocopherol (Vitamin E) in Alzheimer\u2019s disease. J Neural Transm 104: 703\u2013710","journal-title":"J Neural Transm"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(94)91757-4","volume":"639","author":"T Kudo","year":"1994","unstructured":"Kudo T, Iqbal K, Ravid R, Swaab DF, Grundke-Iqbal I (1994) Alzheimer disease: Correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res 639: 1\u20137","journal-title":"Brain Res"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02260965","volume":"7","author":"MA Kuiper","year":"1994","unstructured":"Kuiper MA, Mulder C, Van Kamp GJ, Scheltens P, Wolters EC (1994) Cerebrospinal fluid ferritin levels of patients with Parkinsons\u2019s disease, Alzheimer\u2019s disease, and multiple system atrophy. J Neural Transm [P-D Sect] 7: 109\u2013114","journal-title":"J Neural Transm [P-D Sect]"},{"key":"17_CR28","first-page":"273","volume":"7","author":"M Landen","year":"1996","unstructured":"Landen M, Hesse C, Fredman P, Regland B, Wallin A, Blennow K (1996) Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer\u2019s disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform. Dementia 7: 273\u2013278","journal-title":"Dementia"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0304-3940(95)12059-D","volume":"199","author":"L Lannfelt","year":"1995","unstructured":"Lannfelt L, Basun H, Vigo-Pelfrey C, Wahlund LO, Winblad B, Lieberburg I, Schenk D (1995) Amyloid beta-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Neurosci Lett 199: 203\u2013206","journal-title":"Neurosci Lett"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0304-3940(96)12774-9","volume":"212","author":"D Lefranc","year":"1996","unstructured":"Lefranc D, Vermersch P, Dallongeville J, Daems-Montpeurt C, Petit H, Delacourte A (1996) Relevance of the quantitation of apolipoprotein E in the cerebrospinal fluid in Alzheimer\u2019s disease. Neurosci Lett 212: 91\u201394","journal-title":"Neurosci Lett"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00002093-199509020-00009","volume":"9","author":"F Licastro","year":"1995","unstructured":"Licastro F, Parnetti L, Morini MC, Davis LJ, Cucinotta D, Gaiti A, Senin U (1995) Acute phase reactant alpha-1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alz Dis Assoc Disord 9: 112\u2013118","journal-title":"Alz Dis Assoc Disord"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3940(97)00429-1","volume":"229","author":"M Lindh","year":"1997","unstructured":"Lindh M, Blomberg M, Jensen M, Basun H, Lannfelt L, Engvall B, Scharnagel H, Marz W, Wahlund LO, Cowburn RF (1997) Cerebrospinal fluid apolipoprotein E (ApoE) levels in Alzheimer\u2019s disease patients are increased at follow-up and show a correlation with levels of tau protein. Neurosci Lett 229: 85\u201388","journal-title":"Neurosci Lett"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00002093-199408030-00005","volume":"8","author":"DA Loeffler","year":"1994","unstructured":"Loeffler DA, DeMaggio AJ, Juneau PL, Brickman CM, Mashour GA, Finkelman JH, Pomara N, LeWitt PA (1994) Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer\u2019s disease but not Parkinson\u2019s disease. Alz Dis Assoc Disord 8: 190\u2013197","journal-title":"Alz Dis Assoc Disord"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1023\/A:1027323809229","volume":"22","author":"DA Loeffler","year":"1997","unstructured":"Loeffler DA, Juneau PL, Nguyen HU, Najman D, Pomara N, LeWitt PA (1997) Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer\u2019s disease and normal cerebrospinal fluid. Neurochem Res 22: 209\u2013214","journal-title":"Neurochem Res"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1468-1331.1996.tb00209.x","volume":"3","author":"OL Lopez","year":"1996","unstructured":"Lopez OL, Kaufer D, Reiter CT, Carra J, DeKosky ST, Palmer AM (1996) Relationship between CSF neurotransmitter metabolites and aggressive behavior in Alzheimer\u2019s disease. Eur J Neurol 3: 153\u2013155","journal-title":"Eur J Neurol"},{"key":"17_CR36","first-page":"98","volume":"28","author":"A McRae","year":"1993","unstructured":"McRae A, Eng-Ang-Ling, Wigander A, Dahlstrom A (1993) Microglial cerebrospinal antibodies: significance for Alzheimer disease. Mol Chem Neuropathol 28: 98\u201395","journal-title":"Mol Chem Neuropathol"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0140-6736(85)90074-1","volume":"ii","author":"PD Mehta","year":"1985","unstructured":"Mehta PD, Thal L, Wisniewski HM, Grundke-Iqbal I, Iqbal K (1985) Paired helical filament antigen in CSF. Lancet ii: 35","journal-title":"Lancet"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-510X(96)00234-1","volume":"145","author":"A Merched","year":"1997","unstructured":"Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G (1997) Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer\u2019s disease. J Neurol Sci 145: 33\u201339","journal-title":"J Neurol Sci"},{"key":"17_CR39","first-page":"132","volume":"117","author":"SS Mirra","year":"1993","unstructured":"Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer\u2019s disease: a primer for practicing pathologists. Arch Pathol Lab Med 117: 132\u2013144","journal-title":"Arch Pathol Lab Med"},{"key":"17_CR40","first-page":"275","volume":"26","author":"Y Mochizuki","year":"1996","unstructured":"Mochizuki Y, Oishi M, Hara M, Takasu T (1996) Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia. Ann Clin Lab Sci 26: 275\u2013278","journal-title":"Ann Clin Lab Sci"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0306-4530(93)90044-L","volume":"18","author":"SE Molchan","year":"1993","unstructured":"Molchan SE, Hill LJ, Martinez RA, Lawlor BA, Mellow AM, Rubinow DR, Bissette G, Nemeroff CB, Sunderland T (1993) CSF somatoatatin in Alzheimer\u2019s disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology 18: 509\u2013519","journal-title":"Psychoneuroendocrinology"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0304-3940(95)11291-4","volume":"186","author":"H Mori","year":"1995","unstructured":"Mori H, Hosada K, Matsubara E, Nakamoto T, Furiya Y, Endih R, Usami M, Shoji M, Maruyama S, Hirai S (1995) Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody to the repeat sequence in tau. Neurosci Lett 186: 181\u2013183","journal-title":"Neurosci Lett"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, Southwick P, Wolfert R, Munroe B, Lieberburg I, Seubert P, Schenk D (1995) Reduction of beta-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 38: 643\u2013648","journal-title":"Ann Neurol"},{"key":"17_CR44","first-page":"207","volume":"25","author":"WA Munroe","year":"1995","unstructured":"Munroe WA, Southwick PC, Chang L, Scharre DW, Echols CL, Jr, Fu PC, Whaley JM, Wolfert RL (1995) Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer disease. Ann Clin Lab Sci 25: 207\u2013217","journal-title":"Ann Clin Lab Sci"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0197-4580(97)00057-2","volume":"18","author":"National Institute on Aging and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimers disease","year":"1997","unstructured":"National Institute on Aging and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer\u2019s disease (1997) Consensus recommendations for the post mortem diagosis of Alzheimer\u2019s disease. Neurobiol Aging 18: S1\u2013S3","journal-title":"Neurobiol Aging"},{"key":"17_CR46","first-page":"340","volume":"26","author":"M Oishi","year":"1996","unstructured":"Oishi M, Mochizuki Y, Yoshihashi H, Takasu T, Nakano E (1996) Laboratory examinations correlated with severity of dementia. Ann Clin Lab Sci 26: 340\u2013345","journal-title":"Ann Clin Lab Sci"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H, Zerr I, Lautsch M, Kornhuber J, Weber T, Kretschmer HA, Poser S (1997) Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225: 210\u2013212","journal-title":"Neurosci Lett"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0304-3940(95)12058-C","volume":"199","author":"L Parnetti","year":"1995","unstructured":"Parnetti L, Gaiti A, Polidori MC, Brunetti M, Palumbo B, Chionne F, Cadini D, Cecchetti R, Senin U (1995a) Increased cerebrospinal fluid pyruvate levels in Alzheimer\u2019s disease. Neurosci Lett 199: 231\u2013233","journal-title":"Neurosci Lett"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0304-3940(94)11110-5","volume":"183","author":"L Parnetti","year":"1995","unstructured":"Parnetti L, Palumbo B, Cardinali L, Foreti F, Chionne F, Cechetti R, Senin U (1995b) Cerebrospinal fluid neuron-specific enolase in Alzheimer\u2019s disease and vascular dementia. Neurosci Lett 183: 43\u201345","journal-title":"Neurosci Lett"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0304-3940(96)12810-X","volume":"212","author":"NM Riemenschneider","year":"1996","unstructured":"Riemenschneider NM, Buch K, Schmolke M, Kurz A, Guder WG (1996) Cerebrospinal fluid tau is elevated in early Alzheimer\u2019s disease. Neurosci Lett 212: 209\u2013211","journal-title":"Neurosci Lett"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren LE, Karlsson JE. Karlsson JO, Persson LI, Wikkels C (1996) Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 67: 2013\u20132018","journal-title":"J Neurochem"},{"key":"17_CR52","first-page":"237","volume":"60","author":"N R\u00f6sier","year":"1996","unstructured":"R\u00f6sier N, Wichart I, Jellinger K (1996a) Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 60: 237\u2013238","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/jnnp.60.4.452","volume":"60","author":"N R\u00f6sier","year":"1996","unstructured":"R\u00f6sier N, Wichart I, Jellinger K (1996b) Intra vitam lumbar cerebrospinal fluid and serum and post mortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 60: 452\u2013454","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"17_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0006-3223(88)90190-4","volume":"24","author":"RN Sahu","year":"1988","unstructured":"Sahu RN, Pandey RS, Subhash MN, Arya BYT, Padmashree TS, Srinivas KN (1988) CSF zinc in Alzheimer\u2019s type dementia. Biol Psychiatry 24: 480\u2013482","journal-title":"Biol Psychiatry"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.mp.4000313","volume":"2","author":"J Schr\u00f6der","year":"1997","unstructured":"Schr\u00f6der J, Pantel J, Ida N, Essig M, Hartmann T, Knopp MV, Schad LR, Sandbrink R, Sauer H, Masters CL, Beyreuther K (1997) Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer\u2019s disease: a study with quantitative magnetic resonance imaging. Mol Psychiat 2: 505\u2013507","journal-title":"Mol Psychiat"},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0306-9877(96)90216-9","volume":"47","author":"ZX Shen","year":"1996","unstructured":"Shen ZX (1996) The significance of the activity of CSF cholinesterases in dementias. Med Hypotheses 47: 363\u2013376","journal-title":"Med Hypotheses"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0404.1993.tb04069.x","volume":"87","author":"ZX Shen","year":"1993","unstructured":"Shen ZX, Ding Q, Wei CZ, Ding MC, Meng JM (1993) CSF cholinesterase in early-onset and late-onset Alzheimer\u2019s disease and multi-infarct dementia of Chinese patients. Acta Neurol Scand 87: 19\u201324","journal-title":"Acta Neurol Scand"},{"key":"17_CR58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/clinchem\/42.2.298","volume":"42","author":"HU Shetti","year":"1996","unstructured":"Shetti HU, Holloway HW, Schapiro MB (1996) Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem 42: 298\u2013302","journal-title":"Clin Chem"},{"key":"17_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/archneur.1997.00550150029012","volume":"54","author":"I Skoog","year":"1997","unstructured":"Skoog I, Hesser C, Fredman P, Andreasson LA, Palmertz B, Blennow K (1997) Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects \u2014 relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Arch Neurol 54: 267\u2013272","journal-title":"Arch Neurol"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0197-4580(94)00055-7","volume":"15","author":"MD Smyth","year":"1994","unstructured":"Smyth MD, Cribbs DH, Tenner AJ, Rodman-Shankle W, Dick M, Kesslak JP, Cotman CW (1994) Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state. Neurobiol Aging 15: 609\u2013614","journal-title":"Neurobiol Aging"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1097\/00001756-199512150-00017","volume":"6","author":"H Soininen","year":"1995","unstructured":"Soininen H, Lehtovirta M, Helisalmi S, Linnaranta K, Heinonen O, Riekinnen Sr P (1995) Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon 4 allele. NeuroReport 6: 2518\u20132520","journal-title":"NeuroReport"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0304-3940(97)00558-2","volume":"231","author":"H Song","year":"1997","unstructured":"Song H, Saito K, Seishima M, Noma A, Urakami K, Nakashima K (1997) Cerebrospinal fluid Apo E and Apo A1 concentrations in early and late-onset Alzheimer\u2019s disease. Neurosci Lett 231: 175\u2013178","journal-title":"Neurosci Lett"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1046\/j.1471-4159.1996.66010259.x","volume":"66","author":"PC Southwick","year":"1996","unstructured":"Southwick PC, Yamagata SK, Echols Jr CL, Higson GJ, Neynaber SA, Parson RE, Munroe WA (1996) Assessment of amyloid beta protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer\u2019s disease. J Neurochem 66: 259\u2013265","journal-title":"J Neurochem"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000106598","volume":"8","author":"M Strittmatter","year":"1997","unstructured":"Strittmatter M, Hamann GF, Grauer MT, Cramer H, Schimrigk K (1997a) Neurochemical differences in the CSF between Binswanger\u2019s and Alzheimer\u2019s disease. Dementia Geriatr Cogn Disord 8: 34\u201342","journal-title":"Dementia Geriatr Cogn Disord"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0006-3223(96)00211-9","volume":"41","author":"M Strittmatter","year":"1997","unstructured":"Strittmatter M, Cramer H, Reuner C, Strubel D, Hamann G, Schimrigk K (1997b) Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type. Biol Psychiatry 41: 1124\u20131130","journal-title":"Biol Psychiatry"},{"key":"17_CR66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0022-510X(96)00314-0","volume":"148","author":"A Tamaoka","year":"1997","unstructured":"Tamaoka A, Sawamura N, Fukushima T, Shoji S, Matsubara E, Shoji M, Hirai S, Furiya Y, Endoh H, Mori H (1997) Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neurol Sci 148: 4\u201345","journal-title":"J Neurol Sci"},{"key":"17_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1212\/WNL.50.1.169","volume":"50","author":"T Tapiola","year":"1998","unstructured":"Tapiola T, Lehtovirta M, Ramberg J, et al. (1998) CSF tau is related to apolipoprotein E genotype in early Alzheimer\u2019s disease. Neurology 50: 169\u2013174","journal-title":"Neurology"},{"key":"17_CR68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/jnnp.59.3.280","volume":"59","author":"RE Tato","year":"1995","unstructured":"Tato RE, Frank A, Hernanz A (1995) Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 59: 280\u2013283","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1-2","key":"17_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0304-3940(94)90064-7","volume":"177","author":"H Toghi","year":"1994","unstructured":"Toghi H, Abe T, Hashiguchi K, Saheki M, Takahashi S (1994) Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia. Neurosci Lett 177: 1-2: 139\u2013142","journal-title":"Neurosci Lett"},{"key":"17_CR70","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/BF01271206","volume":"103","author":"H Toghi","year":"1996","unstructured":"Toghi H, Abe T, Kimura M, Saheki M, Takahashi S (1996) Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 103: 1211\u20131220","journal-title":"J Neural Transm"},{"key":"17_CR71","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","volume":"61","author":"M Vandermeeren","year":"1993","unstructured":"Vandermeeren M, Mercken M, Vanmechelen E, Six J, Van-de-Voorde A, Martin JJ, Cras P (1993) Detection of tau proteins in normal and Alzheimer\u2019s disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 61: 1828\u20131834","journal-title":"J Neurochem"},{"key":"17_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-642-46690-8_3","volume-title":"Research and perspectives in Alzheimer disease. Biological markers of Alzheimer disease","author":"HM Wisniewski","year":"1989","unstructured":"Wisniewski HM, Mehta PD, Kim KS, Merz GS (1989) Cerebrospinal fluid based laboratory test for Alzheimer disease. In: Christen Y (ed) Research and perspectives in Alzheimer disease. Biological markers of Alzheimer disease. Springer, Berlin Heidelberg New York Tokyo, pp 23\u201329"},{"key":"17_CR73","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0304-3940(95)11318-Q","volume":"186","author":"K Yamada","year":"1995","unstructured":"Yamada K, Kono K, Umegaki H, Yamada K, Iguchi A, Fukatsu T, Nakashima N, Nishiwaki H, Shimada Y, Sugita Y, Yamamoto T, Hasegawa T, Nabeshima T (1995) Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci Lett 186: 219\u2013221","journal-title":"Neurosci Lett"},{"key":"17_CR74","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0143-4179(95)90003-9","volume":"29","author":"M Yasuda","year":"1995","unstructured":"Yasuda M, Maeda K, Kakigi T, Minamitani N, Kawaguchi T, Tanaka C (1995) Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer\u2019s disease: Altered processing of prepro-vasoactive intestinal polypeptide and prepro-somatostatin. Neuropeptides 29: 325\u2013330","journal-title":"Neuropeptides"}],"container-title":["Journal of Neural Transmission. Supplementa","Ageing and Dementia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-6467-9_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T14:04:38Z","timestamp":1594735478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-6467-9_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"ISBN":["9783211831144","9783709164679"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-6467-9_17","relation":{},"ISSN":["0303-6995"],"issn-type":[{"type":"print","value":"0303-6995"}],"subject":[],"published":{"date-parts":[[1998]]}}}